Doctor profile · Federal record
Dr. Regan Holdridge, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Medical Oncology Physician · Henderson, NV
- NPI 1093937054
- Accepts Medicare
- MIPS 88.9 / 100 · 2023
- 24 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1505 Wigwam Pkwy Ste 130
Henderson, NV 890748195
(702) 856-1400
fax (702) 856-1407 - Mailing address
-
400 N Stephanie St Ste 300
Henderson, NV 890146692
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- February 29, 2024
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Nevada #12846 · Vermont #042-0011321
- Medicaid
- AZ #371315
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093937054. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
96,331
Distinct HCPCS
10
Medicare allowed
$1,332,473
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 28,050 | 31 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 17,250 | 44 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 12,200 | 13 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11,500 | 17 | $3 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 6,290 | 20 | $43 | |
J9267 |
Injection, paclitaxel, 1 mg | 5,160 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 3,240 | 41 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,290 | 85 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,400 | 49 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 936 | 380 | $8 |
In context: peer comparison
Among 4 peers in Henderson Hematology & Oncology Physician, average services per provider: 1,890. This provider delivers 51× the peer median.Open Payments
Industry payments received
All-time total
$131
Transactions
6
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $48.81 | |
| Gilead Sciences, INC. | 1 | $27.48 | |
| Astellas Pharma US INC | 1 | $20.31 | |
| Pfizer INC. | 1 | $20.28 | |
| Daiichi Sankyo INC. | 1 | $13.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
726
Patients
137
Total drug cost
$130,739
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 276 | 82 | $7,472 |
| Xarelto (Rivaroxaban) | Brand | 87 | 15 | $89,888 |
| Letrozole | Generic | 50 | 15 | $1,015 |
| Warfarin Sodium | Generic | 48 | 0 | $499 |
| Prednisone | Generic | 46 | 12 | $333 |
| Gabapentin | Generic | 45 | 13 | $986 |
| Eliquis (Apixaban) | Brand | 33 | 0 | $25,239 |
| Exemestane | Generic | 21 | 0 | $3,144 |
| Tamoxifen Citrate | Generic | 21 | 0 | $407 |
| Levothyroxine Sodium | Generic | 19 | 0 | $274 |
Frequently asked questions
What is Dr. Regan Holdridge's medical specialty?
Dr. Regan Holdridge practices Hematology & Oncology Physician in Henderson, NV.
Where does Dr. Regan Holdridge practice?
Dr. Regan Holdridge practices at 1505 Wigwam Pkwy Ste 130, Henderson, NV 890748195. Office phone: 7028561400.
What is Dr. Regan Holdridge's NPI?
Dr. Regan Holdridge's National Provider Identifier (NPI) is 1093937054, issued by NPPES.
Does Dr. Regan Holdridge accept Medicare assignment?
Yes. Dr. Regan Holdridge accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Regan Holdridge commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.